PRE 14A

PRELIMINARY PROXY STATEMENT

Company: AYTU BIOPHARMA, INC
Filed: February 21, 2020
Period of Report: February 21, 2020
Accession Number: 0001213900-20-004502

View Document ↗ View on SEC.gov ↗